Loading insider details...
Latest Form 4 (Aug 7, 2026): Exercise/Conversion of 45,004 AXSM shares, $222.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 45,004 | $222.8K |
| Jul 1, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 49,666 | $245.8K |
| Jun 9, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 49,670 | $245.9K |
| Apr 24, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 24,081 | n/a |
| Feb 28, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 54,623 | n/a |
| Feb 2, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 32,410 | $259.9K |
| Jan 8, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 78,703 | $631.2K |
| Dec 4, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 49,252 | $395.0K |
| Nov 5, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 91,705 | $735.5K |
| Oct 8, 2025 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 19,220 | $154.1K |